Last reviewed · How we verify

Alternating Acetaminophen and Ibuprofen

Washington University School of Medicine · Phase 3 active Small molecule

Alternating acetaminophen and ibuprofen provides complementary analgesic and anti-inflammatory effects by sequentially blocking different pain and fever pathways.

Alternating acetaminophen and ibuprofen provides complementary analgesic and anti-inflammatory effects by sequentially blocking different pain and fever pathways. Used for Acute pain management (Phase 3 investigational).

At a glance

Generic nameAlternating Acetaminophen and Ibuprofen
Also known asAlternating regimen
SponsorWashington University School of Medicine
Drug classAnalgesic combination therapy
ModalitySmall molecule
Therapeutic areaPain Management
PhasePhase 3

Mechanism of action

Acetaminophen inhibits prostaglandin synthesis primarily in the central nervous system, reducing pain and fever perception. Ibuprofen is a non-selective COX inhibitor that reduces prostaglandin production peripherally and centrally, providing anti-inflammatory and analgesic effects. By alternating these agents, the regimen aims to optimize pain control while potentially reducing individual drug exposure and associated adverse effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: